Atópiás dermatitisz (ekcéma): vizsgálatok itt: Lengyelország
27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Gdansk, Krakow, Łódź, Ostrowiec Świętokrzyski, Rzeszów, Tarnów, Warsaw
- Életkor
- 6 hónap to 11 év
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - 3. fázisNot yet taking people in LengyelországA Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
- Where
- Cracow, Gdansk, Katowice, Kraków, Lodz, Łódź, Lublin, Szczecin, Torun, Warsaw, Warszawa, Wroclaw
- People
- 150 worldwide
- Run by
- Hunan Mabgeek Biotech Co. Ltd.
See details and how to join2025-525022-35-00 · EU 2025-525022-35-00 - 1. fázisTaking peopleFIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Where
- Chorzów, Katowice, Kielce, Lodz, Szczecin
- Életkor
- 18 év to 70 év
- People
- 119 worldwide
- Run by
- Pfizer
See details and how to joinNCT06564389 · EU 2025-524150-34-00 - 3. fázisTaking peopleA Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Where
- Chorzów, Katowice, Krakow, Lodz, Lublin, Ostrowiec Świętokrzyski, Warsaw
- Életkor
- 2 év to 11 év
- People
- 450 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00 - 2. fázisTaking peopleA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Where
- Cracow, Gdansk, Katowice, Kielce, Szczecin
- Életkor
- 18 év to 64 év
- People
- 165 worldwide
- Run by
- Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00 - 2. fázisTaking peopleA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Where
- Gdansk, Katowice, Krakow, Lodz, Lublin, Sosnowiec, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Apogee Therapeutics, Inc.
See details and how to joinNCT07003425 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
- Where
- Bydgoszcz, Chojnice, Gdansk, Katowice, Kielce, Lublin, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Apollo Therapeutics Limited
See details and how to join2026-525673-39-00 · EU 2026-525673-39-00 - 3. fázisCsak meghívásosA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Cracow, Gdansk, Lodz, Warsaw
- Életkor
- 6 hónap to 18 év
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - 2. fázisNot yet taking people in LengyelországA study to investigate the efficacy and safety of TRIV-573 compared with placebo in participants with moderate to severe atopic dermatitis
- Where
- Katowice, Kielce, Lublin, Mikolow, Nowa Sol, Poznan, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- Triveni Bio Inc.
See details and how to join2026-526485-25-00 · EU 2026-526485-25-00 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Bialystok, Białystok, Chorzów, Cracow, Gdansk, Katowice, Lodz, Lublin, Poznan, Szczecin, Warszawa, Wroclaw
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00 - 3. fázisNot yet taking people in LengyelországA Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
- Where
- Gdansk, Rzeszów, Warsaw, Wroclaw
- Életkor
- 12 év and over
- People
- 230 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00 - 1. fázisTaking peopleA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- Where
- Lodz, Rzeszów, Warsaw, Wroclaw
- Életkor
- 18 év to 72 év
- People
- 237 worldwide
- Run by
- Bambusa Therapeutics
See details and how to joinNCT06808477 · EU 2025-522918-23-00 - 2. fázisNot yet taking people in LengyelországA study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis
- Where
- Cracow, Gdansk, Lublin, Piotrkow Trybunalski, Sosnowiec, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Enveda Therapeutics Inc.
See details and how to join2026-526184-38-00 · EU 2026-526184-38-00 - 2. fázisTaking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Katowice, Lodz, Lublin, Warsaw
- Életkor
- 18 év to 100 év
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - 3. fázisTaking peopleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Where
- Chorzów, Katowice, Krakow, Łódź, Lublin, Ostrowiec Świętokrzyski, Warsaw
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807268 · EU 2023-509121-51-00 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Bialystok, Chorzów, Cracow, Gdynia, Iwonicz-Zdroj, Krakow, Lublin, Malbork, Rzeszów, Szczecin, Tarnów, Torun, Warsaw, Warszawa
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07711418 · EU 2025-525129-11-00 - 1. fázisTaking peopleA Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
- Where
- Gdansk, Wroclaw
- Életkor
- 18 év to 64 év
- People
- 291 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 · EU 2025-523826-41-00 - 1. fázisTaking peopleA first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.
- Where
- Białystok, Janki, Katowice, Kielce, Ozarowice, Wroclaw
- Életkor
- 18 év to 64 év
- People
- 80 worldwide
- Run by
- Egle Therapeutics
See details and how to join2025-521658-40-00 · EU 2025-521658-40-00 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Bydgoszcz, Chojnice, Gdansk, Katowice, Kielce, Lublin, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év to 65 év
- People
- 280 worldwide
- Run by
- Apollo Therapeutics Ltd
See details and how to joinNCT07599813 - 2. fázisTaking peopleA Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
- Where
- Cracow, Gdansk, Katowice, Lodz, Lublin, Sosnowiec, Szczecin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- Apogee Therapeutics Inc.
See details and how to join2024-519795-11-00 · EU 2024-519795-11-00 - 2. fázisTaking peoplePharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
- Where
- Gdansk, Krakow, Lublin, Rzeszów, Sosnowiec, Tarnów, Warsaw
- Életkor
- 6 hónap to 23 hónap
- People
- 35 worldwide
- Run by
- Galderma R&D
See details and how to joinNCT07660835 · EU 2025-525027-27-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Bialystok, Chorzów, Cracow, Gdansk, Katowice, Kielce, Lublin, Nowa Sol, Nowy Targ, Poznan, Sosnowiec, Szczecin, Tarnów, Warsaw, Warszawa, Wroclaw
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00 - No phaseTaking peopleEffect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
- Where
- Bialystok, Warsaw
- Életkor
- 1 nap to 14 nap
- People
- 400 worldwide
- Run by
- Société des Produits Nestlé (SPN)
See details and how to joinNCT06943469 - 2. fázisTaking peopleStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD
- Where
- Cracow, Łódź, Rzeszów, Szczecin, Warszawa, Wroclaw
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00 - No phaseNot yet taking people in LengyelországURGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis
- Where
- Gdansk, Malbork
- Életkor
- 18 év and over
- People
- 44
- Run by
- CEN Biotech
See details and how to joinNCT07295678